Loading...
Header Logo
Keywords
Last Name
Institution

Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer.


Collapse Biography 
Collapse contributor

Collapse Overview 
Collapse sponsor award id
2R44CA224472-01-A1

Collapse Time 
Collapse start date
2018-08-22
Collapse end date
2021-08-21